Biodesix raises 2026 revenue outlook to $108M-$114M as it targets sustained adjusted EBITDA profitability
Biodesix, Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $15.27
+2.5% in 3d after detection
Post-detection moves
1h
—
1d
+0.4%
3d
+2.5%
7d
-1.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS